NajatBouchkoujMD

Assistant Professor, Pediatrics, Georgetown University School of Medicine

Dr. Bouchkouj is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3800 Reservoir Rd NW
Washington, DC 20007
Phone+1 202-444-7599

Fax+1 202-444-8817

Children's National Hospital/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 2007 - 2010
SUNY Downstate Health Sciences UniversityResidency, Pediatrics, 2003 - 2006
Damascus University Faculty of MedicineClass of 2001

PubMed

13 citations
FDA Approval Summary: Brexucabtagene Autoleucel for Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia.
Najat Bouchkouj, Xue Lin, Xiaofei Wang, Donna Przepiorka, Zhenzhen Xu
The Oncologist. 2022-10-01
Regulatory Aspects of Gene Therapy: The Regulatory Life Cycle.
Najat Bouchkouj, Megha Kaushal, Poornima Sharma, Kristin Baird
Hematology/oncology Clinics of North America. 2022-08-01
3 citations
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma.
Najat Bouchkouj, Megan Zimmerman, Yvette L Kasamon, Cong Wang, Tianjiao Dai
The Oncologist. 2022-07-05

Abstracts/Posters

2017-2018 Hematology Drug Approvals at the Food and Drug Administration (FDA): Communication of Patient-Reported Outcomes (PRO) Information in FDA Clinical Reviews and...
Najat Bouchkouj, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Regulatory Challenges Related to Cell-Based Therapies. Shepherding Cell Based Cancer Therapeutics Toward Approval
2018 ASCO Annual Meeting - Chicago, Illinois - 05/31/2018